rt-pa

Key facts

Mechanism of action

Tissue-type plasminogen activator exogenous protein

Primary target: Tissue-type plasminogen activator

Approval history

1. D9103C00001 Phase 3 · AstraZeneca · Main cohort: Patients with unresected Stage I/II, lymph-node
2. rt-PA Phase 3 · Beijing Tiantan Hospital · Acute Ischemic Stroke
3. GnP in combination with Ivonescimab and SBRT Phase 2 · Chinese Academy of · Pancreatic Cancer
4. Recombinant tissue plasminogen activator (rt-PA) Approved · Chinese Academy of · Pulmonary Thromboembolisms
5. rt-PA Approved · Takeda · Lacunar Stroke

1. alteplase Tissue-type plasminogen activator exogenous protein
2. reteplase Blood and blood forming organs (B01)
3. tenecteplase Blood and blood forming organs (B01)
4. rhtnk-tpa Tissue-type plasminogen activator exogenous protein

Frequently asked questions